Analyst stock forecast
ImageneBio Forecast: $18.00 Analyst Target
Direct answer
ImageneBio's average price target is $18.00.
The target implies +281.4% from the recorded current price, and the consensus rating is none.
The low target implies -57.6%, the high target implies +493.2%, and the range spans 550.8% of the current price.
Forecast evidence checked September 26, 2026.
Get free ImageneBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.72
- Average price target
- $18.00
- High price target
- $28.00
- Low price target
- $2.00
- Low target gap
- -57.6%
- Target upside
- +281.4%
- High target gap
- +493.2%
- Target range width
- 550.8%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 26, 2026
- Valid through
- October 3, 2026
Explore related company data
Read the frequently asked questions.
What is ImageneBio's average price target?
ImageneBio's verified average price target is $18.00. The target range is $2.00 to $28.00.
How far are ImageneBio's low and high targets from the recorded price?
The low target implies -57.6%, while the high target implies +493.2%.
How many analysts are included in ImageneBio's consensus?
The verified consensus includes 3 analysts.
How is ImageneBio's target upside or downside calculated?
The average target of $18.00 is divided by the recorded price of $4.72, then one is subtracted to produce +281.4%. This does not guarantee a future return.
When was ImageneBio's analyst forecast verified?
The data was verified on 2026-09-26. The dataset is valid through 2026-10-03.